CAPE TOWN, South Africa — The Trump administration has provided a $99.6 million loan to a U.S.-owned cell phone network operator in Africa to expand American tech presence on a continent where China’s Huawei is a leading player. The loan from the U.S. government’s Export-Import Bank was announced by the operator Africell on Friday. It
Bunne, C. et al. How to build the virtual cell with artificial intelligence: priorities and opportunities. Cell 187, 7045–7063 (2024). Article CAS PubMed PubMed Central Google Scholar Qian, L., Dong, Z. & Guo, T. Grow AI virtual cells: three data pillars and closed-loop learning. Cell Res. 35, 319–321 (2025). Article PubMed PubMed Central Google Scholar
Memorial Day weekend 2024 started with a blue sky and a mild three- to four-foot chop in the water off the Gulf Coast of Mississippi — a perfect day for a fishing competition. A team of five was about 40 miles offshore checking their sonar, and 30 seconds later the boat was gone. They were in the
Exploratory biomarker analyses were performed in 190 patients (nivolumab, 98 out of 229 (43%); placebo, 92 out of 232 (40%)) with evaluable paired tumour samples from screening and blood samples from ≥1 time point during the study for whole-exome sequencing (WES). These individuals constituted the biomarker-evaluable population. The most common reasons for exclusion were samples
Kucewicz, M. T., Worrell, G. A. & Axmacher, N. Direct electrical brain stimulation of human memory: lessons learnt and future perspectives. Brain 146, 2214–2226 (2023). Article PubMed Google Scholar Ezzyat, Y. et al. Closed-loop stimulation of temporal cortex rescues functional networks and improves memory. Nat. Commun. 9, 365 (2018). Article ADS PubMed PubMed Central Google
Conrad, M. et al. Cell death in cancer. Cell 189, 2322–2356 (2026). Article PubMed CAS Google Scholar Mao, C., Jiang, D., Koong, A. C. & Gan, B. Exploiting metabolic cell death for cancer therapy. Nat. Rev. Cancer 26, 27–45 (2026). Article PubMed CAS Google Scholar Amaria, R. N. et al. Neoadjuvant relatlimab and nivolumab in